1. Fortuny J, Johnson C, Bohlke K, Chow WH, Hart G, Kucera G, Mujumdar U, Ownby D, Wells K, Yood MU, Engel LS. Use of anti inflammatory drugs and lower esophageal sphincter relaxing drugs and risk of esophageal and gastric cancers. Clinical Gastroenterology and Hepatology, 2007 (in press)
2. Kricker A, Armstrong BK, Goumas C, Litchfield M, Begg CB, Hummer AJ, Marrett LD, Theis B, Millikan RC, Thomas N, Anton-Culver H, Gallagher RP, Dwyer T, Rebbeck T, Busam K, From L, Mujumdar U, Zanetti R, Berwick M. Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes and Control. 18(3): 295-304, 2007 [PubMed Abstract]
3. Orlow I, Begg CB, Cotignola J, Roy P, Hummer AJ, Clas BA, Mujumdar U, Canchola R, Armstrong BK, Kricker A, Marrett LD, Millika RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Wilcox H, Busam K, From L and Berwick M for The GEM Study Group. CDKN2A Germline Mutations in Individuals with Cutaneous Malignant Melanoma. Journal of Investigative Dermatology. 127 (5): 1234-43, 2007 [PubMed Abstract]
4. Kanetsky PA, Rebbeck TR, Hummer AJ, Panossian S, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Busam K, From L, Mujumdar U, Wilcox H, Begg CB, Berwick M. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma, Cancer Research, 66 (18): 9330-7, 2006. [PubMed Abstract]
5. Berwick M, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Busam K, From L, Mujumdar U, Wilcox H, Begg CB for the GEM Study Group. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer Epidemiology Biomarkers and Prevention, 15(8): 1520-5, 2006. [PubMed Abstract]
6. Begg CB, Hummer AJ, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Busam K, From L, Berwick M for the GEM Study Group. A design for case-control studies using only incident cases: experience with the GEM study of melanoma. International Journal of Epidemiology, 35(3): 756-64, 2006. [PubMed Abstract]
7. Millikan RC, Hummer A, Begg C, Player J, de Cotret AR, Winkel S, Mohrenweiser H, Thomas N, Armstrong B, Kricker A, Marrett LD, Gruber SB, Anton Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck T, Busam K, From L, Mujumdar U, Berwick M for the GEM Study Group. Polymorphisms in Nucleotide Excision Repair Genes and Risk of Multiple Primary Melanoma: the Genes Environment and Melanoma Study. Carcinogenesis. 27(3): 610-8, 2006. [PubMed Abstract]
8. Hay JL, Ostroff JS, Martin A, Soma S, Serle N, Mujumdar U, Berwick M. Skin cancer risk discussions in melanoma-affected families. Journal of Cancer Education. 20 (4): 240-6, 2005. [PubMed Abstract]
9. Begg CB, Hummer A, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Klotz JB, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Berwick MR. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes and Control. 15: 957-65, 2004. [PubMed Abstract]
10. Busam KJ, Mujumdar U, Hummer AJ, Nobrega J, Hawkins WG, Coit DG, Brady MS. Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors. American Journal of Surgical Pathology. 28: 1518-25, 2004. [PubMed Abstract]
11. Gruber SB, Entius MM, Petersen GM, Laken SJ, Longo PA, Boyer R, Levin AM, Mujumdar UJ, Trent JM, Kinzler KW, Vogelstein B, Hamilton SR, Polymeropoulos MH, Offerhaus GH, and Giardiello FM. Pathogenesis of adenocarcinoma in Peutz-Jeghers Syndrome. Cancer Research, 58 (23): 5267-5270, 1998. [PubMed Abstract]
